Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
|
|
Aura Biosciences, Inc. (AURA)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/05/2023 |
4
| Johnson David Michael (Director) has filed a Form 4 on Aura Biosciences, Inc.|
Txns:
| Bought 13,500 shares
@ $8.2713, valued at
$111.7k
Bought 6,566 shares
@ $8.6068, valued at
$56.5k
|
|
| 06/09/2023 |
4
| Mattessich Antony C. (Director) has filed a Form 4 on Aura Biosciences, Inc.|
Txns:
| Granted 16,000 options to buy
@ $12.83, valued at
$205.3k
|
|
| 06/09/2023 |
4
| Johnson David Michael (Director) has filed a Form 4 on Aura Biosciences, Inc.|
Txns:
| Granted 16,000 options to buy
@ $12.83, valued at
$205.3k
|
|
| 06/09/2023 |
4
| PAREKH RAJESH B (Director) has filed a Form 4 on Aura Biosciences, Inc.|
Txns:
| Granted 16,000 options to buy
@ $12.83, valued at
$205.3k
|
|
| 06/09/2023 |
4
| Srivastava Sapna (Director) has filed a Form 4 on Aura Biosciences, Inc.|
Txns:
| Granted 16,000 options to buy
@ $12.83, valued at
$205.3k
|
|
| 01/23/2023 |
4
| Feder Julie B (CFO) has filed a Form 4 on Aura Biosciences, Inc.|
Txns:
| Granted 48,750 shares
@ $0
Granted 75,000 options to buy
@ $10.18, valued at
$763.5k
|
|
| 01/23/2023 |
4
| De Rosch Mark (COO) has filed a Form 4 on Aura Biosciences, Inc.|
Txns:
| Granted 42,250 shares
@ $0
Granted 65,000 options to buy
@ $10.18, valued at
$661.7k
|
|
| 01/23/2023 |
4
| de los Pinos Elisabet (See Remarks) has filed a Form 4 on Aura Biosciences, Inc.|
Txns:
| Granted 121,875 shares
@ $0
Granted 187,500 options to buy
@ $10.18, valued at
$1.9M
|
|
| 01/23/2023 |
4
| Rich Cadmus (See Remarks) has filed a Form 4 on Aura Biosciences, Inc.|
Txns:
| Granted 34,125 shares
@ $0
Granted 52,500 options to buy
@ $10.18, valued at
$534.5k
|
|
| 01/09/2023 |
4
| Johnson David Michael (Director) has filed a Form 4 on Aura Biosciences, Inc.|
Txns:
| Bought 300 shares
@ $10, valued at
$3k
Bought 96 shares
@ $10, valued at
$960
Bought 700 shares
@ $10.5, valued at
$7.4k
Bought 904 shares
@ $10.51, valued at
$9.5k
|
|
| 12/30/2022 |
4
| Johnson David Michael (Director) has filed a Form 4 on Aura Biosciences, Inc.|
Txns:
| Bought 2,000 shares
@ $9.75, valued at
$19.5k
Bought 2,000 shares
@ $9.75, valued at
$19.5k
|
|
| 12/15/2022 |
4
| Johnson David Michael (Director) has filed a Form 4 on Aura Biosciences, Inc.|
Txns:
| Bought 5,000 shares
@ $12.37, valued at
$61.9k
Bought 5,000 shares
@ $12.37, valued at
$61.9k
|
|
| 12/07/2022 |
4
| Matrix Capital Management Company, LP (10% Owner) has filed a Form 4 on Aura Biosciences, Inc.|
Txns:
| Bought 1,250,000 shares
@ $12, valued at
$15M
|
|
| 11/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2022 |
4
| Johnson David Michael (Director) has filed a Form 4 on Aura Biosciences, Inc.|
Txns:
| Granted 16,000 options to buy
@ $13.72, valued at
$219.5k
|
|
| 06/17/2022 |
4
| Srivastava Sapna (Director) has filed a Form 4 on Aura Biosciences, Inc.|
Txns:
| Granted 16,000 options to buy
@ $13.72, valued at
$219.5k
|
|
| 06/17/2022 |
4
| Mattessich Antony C. (Director) has filed a Form 4 on Aura Biosciences, Inc.|
Txns:
| Granted 16,000 options to buy
@ $13.72, valued at
$219.5k
|
|
| 06/14/2022 |
4
| Johnson David Michael (Director) has filed a Form 4 on Aura Biosciences, Inc.|
Txns:
| Bought 3,000 shares
@ $15.04, valued at
$45.1k
Bought 3,000 shares
@ $15.04, valued at
$45.1k
Bought 10,000 shares
@ $15.04, valued at
$150.4k
Bought 7,000 shares
@ $13.99, valued at
$97.9k
Bought 7,000 shares
@ $13.99, valued at
$97.9k
Bought 20,000 shares
@ $13.99, valued at
$279.8k
|
|
| 11/04/2021 |
4
| Matrix Capital Management Company, LP (10% Owner) has filed a Form 4 on Aura Biosciences, Inc.|
Txns:
| Converted 2,327,870 shares
@ $0
Bought 1,785,000 shares
@ $14, valued at
$25M
Converted 2,327,870 convertible preferred
@ $0 |
|
| 11/02/2021 |
4
| de los Pinos Elisabet (See Remarks) has filed a Form 4 on Aura Biosciences, Inc.|
Txns:
| Converted 4,552 shares
@ $0
Converted 3,042 preferred shares
@ $0
Converted 1,510 preferred shares
@ $0 |
|
| 11/02/2021 |
4
| Johnson David Michael (Director) has filed a Form 4 on Aura Biosciences, Inc.|
Txns:
| Converted 139,672 shares
@ $0
Converted 139,672 convertible preferred
@ $0 |
|
| 10/29/2021 |
4
| Johnson David Michael (Director) has filed a Form 4 on Aura Biosciences, Inc.|
Txns:
| Granted 24,000 options to buy
@ $14, valued at
$336k
|
|
| 10/29/2021 |
4
| Rich Cadmus (See Remarks) has filed a Form 4 on Aura Biosciences, Inc.|
Txns:
| Granted 26,250 shares
@ $0
Granted 112,500 options to buy
@ $14, valued at
$1.6M
|
|
| 10/29/2021 |
4
| de los Pinos Elisabet (See Remarks) has filed a Form 4 on Aura Biosciences, Inc.|
Txns:
| Granted 74,357 shares
@ $0
Granted 318,750 options to buy
@ $14, valued at
$4.5M
|
|
| 10/29/2021 |
4
| De Rosch Mark (COO) has filed a Form 4 on Aura Biosciences, Inc.|
Txns:
| Granted 17,500 shares
@ $0
Granted 75,000 options to buy
@ $14, valued at
$1.1M
|
|
| 10/29/2021 |
4
| Mattessich Antony C. (Director) has filed a Form 4 on Aura Biosciences, Inc.|
Txns:
| Granted 16,000 options to buy
@ $14, valued at
$224k
|
|
| 10/29/2021 |
4
| Feder Julie B (CFO) has filed a Form 4 on Aura Biosciences, Inc.|
Txns:
| Granted 26,250 shares
@ $0
Granted 112,500 options to buy
@ $14, valued at
$1.6M
|
|
| 10/29/2021 |
4
| PAREKH RAJESH B (Director) has filed a Form 4 on Aura Biosciences, Inc.|
Txns:
| Granted 16,000 options to buy
@ $14, valued at
$224k
|
|
| 10/29/2021 |
4
| Primiano Christopher Brett (Chief Business Officer) has filed a Form 4 on Aura Biosciences, Inc.|
Txns:
| Granted 8,750 shares
@ $0
Granted 37,500 options to buy
@ $14, valued at
$525k
|
|
| 10/29/2021 |
4
| Srivastava Sapna (Director) has filed a Form 4 on Aura Biosciences, Inc.|
Txns:
| Granted 16,000 options to buy
@ $14, valued at
$224k
|
|
|
|
|